Digestive EmergencyRAUCAMIENSNCT06769438
Effectiveness of the RAUC Pathway in Reducing Unscheduled Hospitalizations After Emergency Digestive Surgery
A study testing ERAS, DEEPSEN and RDS in people with Digestive Emergency and New Pathway, run by Centre Hospitalier Universitaire, Amiens at 6 sites in France.
Trial summary
The number of emergencies's visits (22 million visits in 2019 in France), the organization of emergencies and the sustainability of the current health system are threatened. In the CHUAP adult emergency department, 60,000 visits were recorded in 2022. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Digestive Emergency, New Pathway, Connected Health
- What is being tested?
- ERAS, DEEPSEN and RDS
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 3,048 participants
- Where
- 6 sitesFrance
- Study dates
- 2 Jun 2025to Feb 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Criterion linked to the protocol :
- -- Patient consulted in emergency for a digestive pathology requiring surgery
- Search criteria:
- Adult patient (≥ 18 years old),
- Able to give consent,
- Affiliation to a social security scheme
Who cannot join
- Criterion linked to the protocol:
- Patient leaving hospitalization to a convalescent center
- Patient requiring direct operating room (vital emergency or surgical revision)
- Patient presenting to the emergency room for a postoperative complication
- Patient directly admitted to intensive care
- Search criteria:
- Pregnant or breastfeeding woman
- Patient under guardianship, curatorship or deprived of liberty
Trial locations and contacts
6 sites in 1 country. Contact the study team or a site near you to ask about taking part.
6 sites in 1 country
France6 sites, 6 recruiting
- Recruiting
CHU Angers
Angers, 49933
- Recruiting
Centre Hospitalier de Beauvais
Beauvais, Oise, 60000
- Recruiting
Hopital Avicenne APHP
Bobigny, 95300
- Recruiting
Hopital Cochin - Port Royal APHP
Paris, 75014
- Recruiting
CHU Rouen
Rouen, 76000
- Recruiting
Centre Hospitalier Universitaire, Amiens
Salouël, 80480
Jean Marc Regimbeau, Pr, 33 + 322 088 897, regimbeau.jean-marc@chu-amiens.fr
About this study
Official title: Effectiveness of the Augmented Rehabilitation of Digestive Surgical Emergencies Pathway in Reducing Unscheduled Hospitalizations After Surgery
The number of emergencies's visits (22 million visits in 2019 in France), the organization of emergencies and the sustainability of the current health system are threatened. In the CHUAP adult emergency department, 60,000 visits were recorded in 2022.
Unlike medical emergencies which have structured their care and research activities (heart, brain), and whose organization has demonstrated its general interest for society, digestive surgical emergencies, which involve complex patients (elderly people, comorbidities) , emergency situations and surgical procedures, have never been thought of globally in terms of personalized care and research pathways. Currently, patients treated in emergency are managed without a pre-established optimization program and without a dedicated pathway, where emergency constitutes a major risk factor for postoperative complications.
RAUCAMIENS evaluates a new care pathway implemented within the framework of the RHU RAUC : the implementation of the Enhanced rehabilitation after surgery (ERAS) and e-health devices for home monitoring, for patients treated in the emergency room for a digestive pathology. The purpose is to evaluate the effectiveness of the RAUC pathway in reducing the rate of unplanned hospitalization readmission after emergency digestive surgery 30 days postoperative.
- Conditions
- Digestive Emergency, New Pathway, Connected Health
- Being tested
- ERAS, DEEPSEN, RDS, Get ready, Lumiradx
- Keywords
- digestive emergency, new pathway, connected health
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ERASOther
ERAS
DEEPSENOther
virtual reality headset to reduce anxiety
RDSOther
patch to continuously monitor patients' physiological parameters at home
Get readyOther
digital solution for managing patients at home
LumiradxOther
taking CRP at home
Digital SurgeryOther
recording of the different operating times
| Study group | Role | What they receive |
|---|---|---|
| Experimental group | Experimental | patients included in the CHUAP RAUC + course Receives: Other: ERAS; Other: DEEPSEN; Other: RDS; Other: Get ready; Other: Lumiradx; Other: Digital Surgery |
| Control group 1 | Active comparator | patients from other hospital included over the same period as patients from CHUAP benefiting from standard care (RAUC -) Receives: Other: ERAS |
| Control group 2 | Active comparator | patients verifying the inclusion/non-inclusion criteria and from the SNDS over the period from January 1, 2022 to December 31, 2025 Receives: Other: ERAS |
What is being measured
The primary outcome is the main question the study is designed to answer.
Occurrence of an unscheduled hospitalization readmission
Occurrence of an unscheduled hospitalization readmission following digestive surgery performed urgently within 30 days
Measured: 30 days
Secondary outcomes (6)
assess morbidity and mortality
Clavien-Dindo score
Measured: 30 days
evaluaate the effectiveness of the RAUC pathway on the lenght of hospital stay on first admission for emergency digestive surgery
lenght of hospital stay for first admission for emergency digestive surgery
Measured: 30 days
evaluate the quality of life of patients with or without a RAUC pathway
Quality of life assessed by the scores of the different dimensions of the EQ-5D-5L which is a PROMS, at admission and the postoperative visit
Measured: 0 day
Assessing patient anxietys
Anxiety assessed by a VAS
Measured: 30 days
assess wether the patient has returned to the emergency department without being hospitalized
non-hospitalized emergency room visits
Measured: 0 day
medico economic evaluation of the RAUC pathway
incremental cost-utility ratio (cost/QALY) and ncremental cost-effectiveness ratio (cost per readmission avoided)
Measured: 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jan 2025
- Study start2 Jun 2025
- Primary completionJul 2027 (estimated)
- Study completionFeb 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Digestive EmergencyStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire, AmiensThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 3,048 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Sponsor type
- University, hospital or other
- Collaborators
- University Hospital, Rouen, Centre Hospitalier de Beauvais, University Hospital, Angers, Hôpital Cochin, Assistance Publique Hopitaux Paris AVICENNE
- Responsible party
- Sponsor
- Investigators
- Jean Marc Regimbeau, Pr, Principal investigator, CHRU Amiens
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06769438
- Sponsor's protocol ID
- PI2024_843_0094
- Acronym
- RAUCAMIENS
- Status last verified
- Oct 2026
- First submitted
- 7 Jan 2025
- Last updated
- 2 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of the Augmented Rehabilitation of Digestive Surgical Emergencies Pathway in Reducing Unscheduled Hospitalizations After Surgery
- ClinicalTrials.gov ID
- NCT06769438
- Acronym / sponsor ID
- RAUCAMIENS / PI2024_843_0094
- Conditions
- Digestive Emergency, New Pathway, Connected Health
- Keywords
- digestive emergency, new pathway, connected health
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 3,048 participants (estimated)
- Lead sponsor
- Centre Hospitalier Universitaire, AmiensUniversity, hospital or other
- Collaborators
- University Hospital, Rouen, Centre Hospitalier de Beauvais, University Hospital, Angers, Hôpital Cochin, Assistance Publique Hopitaux Paris AVICENNE
- Study start
- 2 Jun 2025 (actual)
- Primary completion
- Jul 2027 (estimated)
- Study completion
- Feb 2028 (estimated)
- First posted
- 10 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The number of emergencies's visits (22 million visits in 2019 in France), the organization of emergencies and the sustainability of the current health system are threatened. In the CHUAP adult emergency department, 60,000 visits were recorded in 2022.
Unlike medical emergencies which have structured their care and research activities (heart, brain), and whose organization has demonstrated its general interest for society, digestive surgical emergencies, which involve complex patients (elderly people, comorbidities) , emergency situations and surgical procedures, have never been thought of globally in terms of personalized care and research pathways. Currently, patients treated in emergency are managed without a pre-established optimization program and without a dedicated pathway, where emergency constitutes a major risk factor for postoperative complications.
RAUCAMIENS evaluates a new care pathway implemented within the framework of the RHU RAUC : the implementation of the Enhanced rehabilitation after surgery (ERAS) and e-health devices for home monitoring, for patients treated in the emergency room for a digestive pathology. The purpose is to evaluate the effectiveness of the RAUC pathway in reducing the rate of unplanned hospitalization readmission after emergency digestive surgery 30 days postoperative.
Study design
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Experimental group | Experimental | Other: ERAS, Other: DEEPSEN, Other: RDS, Other: Get ready, Other: Lumiradx, Other: Digital Surgerypatients included in the CHUAP RAUC + course |
| Control group 1 | Active comparator | Other: ERASpatients from other hospital included over the same period as patients from CHUAP benefiting from standard care (RAUC -) |
| Control group 2 | Active comparator | Other: ERASpatients verifying the inclusion/non-inclusion criteria and from the SNDS over the period from January 1, 2022 to December 31, 2025 |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Criterion linked to the protocol :
- -- Patient consulted in emergency for a digestive pathology requiring surgery
- Search criteria:
Key exclusion criteria (8 listed)
- Criterion linked to the protocol:
- Search criteria:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ERASERAS | Other | Control group 1, Control group 2, Experimental group |
| DEEPSENvirtual reality headset to reduce anxiety | Other | Experimental group |
| RDSpatch to continuously monitor patients' physiological parameters at home | Other | Experimental group |
| Get readydigital solution for managing patients at home | Other | Experimental group |
| Lumiradxtaking CRP at home | Other | Experimental group |
| Digital Surgeryrecording of the different operating times | Other | Experimental group |
Primary outcome
Occurrence of an unscheduled hospitalization readmission
Time frame: 30 days
Occurrence of an unscheduled hospitalization readmission following digestive surgery performed urgently within 30 days
6 secondary outcomes
assess morbidity and mortality
Time frame: 30 days
evaluaate the effectiveness of the RAUC pathway on the lenght of hospital stay on first admission for emergency digestive surgery
Time frame: 30 days
evaluate the quality of life of patients with or without a RAUC pathway
Time frame: 0 day
Assessing patient anxietys
Time frame: 30 days
assess wether the patient has returned to the emergency department without being hospitalized
Time frame: 0 day
medico economic evaluation of the RAUC pathway
Time frame: 30 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Nov 2026.
- Individual participant dataSharing planned: No
Related trials for Digestive Emergency
RecruitingObservational study
AIDE: Decision Support for Anastomosis or Colostomy in Emergency Surgery for Complicated Acute Diverticulitis
Complicated Diverticulitis, Acute Diverticulitis
Active, not recruitingPhase 4
Early vs Postponed Parenteral Nutrition After Emergency Abdominal Surgery
Laparotomy, Bowel Obstruction
Active, not recruiting
PAINED: Project Addressing INequities in the Emergency Department
Pain, Appendicitis
RecruitingPhase 3
Morphine or Ketamine for Analgesia
Abdominal Pain, Isolated Extremity Fracture
Recruiting
Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up
Genital Diseases, Female, Ectopic Pregnancy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Jean Marc Regimbeau, Pr principal investigator
CHRU Amiens
6 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ERAS, DEEPSEN and RDS in people with Digestive Emergency and New Pathway, run by Centre Hospitalier Universitaire, Amiens at 6 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 6 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jean Marc Regimbeau, Pr (33 + 322 088 897, regimbeau.jean-marc@chu-amiens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Occurrence of an unscheduled hospitalization readmission (time frame: 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.